Arkadios Wealth Advisors Moderna, Inc. Call Options Transaction History

Arkadios Wealth Advisors

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 30, 2024	SELL	$85.37 - $115.44 $409,776 - $554,112	-4,800 Reduced 65.75%	2,500 $266,000
Q4 2023 Jan 24, 2024	SELL	$69.51 - $104.43 $187,677 - $281,961	-2,700 Reduced 27.0%	7,300 $725,000
Q3 2023 Oct 13, 2023	BUY	$96.41 - $126.61 $482,050 - $633,050	5,000 Added 100.0%	10,000 $1.03 Million
Q1 2023 May 02, 2023	BUY	$135.66 - $197.02 $339,150 - $492,550	2,500 Added 100.0%	5,000 $767,000
Q4 2022 Jan 11, 2023	SELL	$118.38 - $210.04 $295,950 - $525,100	-2,500 Reduced 50.0%	2,500 $0

Q3 2022 Oct 21, 2022	SELL	$118.07 - $194.18 $1 Million - $1.65 Million	-8,500 Reduced 62.96%	5,000 $591,000
Q2 2022 Jul 14, 2022	BUY	$117.13 - $176.59 $702,780 - $1.06 Million	6,000 Added 80.0%	13,500 $1.93 Million
Q1 2022 May 02, 2022	SELL	$126.46 - $235.05 $948,450 - $1.76 Million	-7,500 Reduced 50.0%	7,500 $1.29 Million
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $3.39 Million - $5.53 Million	15,000 New	15,000 $3.81 Million

1,038

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.